Last mentioned: Mar 9, 2026
Seveno Capital has announced a strategic investment in PointFit, a health-tech startup developing next-generation skin-interfaced wearable patches. The deal signals a significant venture capital shift away from traditional wrist-worn devices toward non-invasive biochemical monitoring.
Seveno Capital has announced a strategic investment in PointFit, a biotech startup developing a non-invasive sweat-sensing skin patch. The partnership aims to transition the wearable market from mechanical tracking to real-time biochemical analysis using proprietary nanomembrane technology.
Seveno Capital has announced a strategic investment in PointFit, a health-tech firm developing a non-invasive wearable patch that monitors health metrics through sweat. This move signals a growing investor shift away from consumer-grade wrist devices toward specialized, medical-grade skin patches for continuous monitoring.